Authors: Joseph P. Cravero, M.D., FAAP et al ASA Monitor 11 2016, Vol.80, 28-30. Opioids represent one of the time-honored tools for pediatric anesthesiologists in treating the most significant pain and suffering that confront our patients. While we continue to seek adequate pain treatment and avoid the consequences of inadequately treated pain, the reality of the ongoing […]
Read MoreAuthors: Caleb H. Ing, M.D., M.S. et al ASA Monitor 11 2016, Vol.80, 16-18. The possibility of anesthetic neurotoxicity was first suggested more than 15 years ago with findings of apoptosis in the brains of rodents after ethanol exposure during critical periods of neurodevelopment. A similar neuroapoptotic effect was soon identified in anesthetic agents and linked to […]
Read MoreAuthor: John Pfitzner, M.B.B.S., F.R.C.A. Anesthesiology 12 2016, Vol.125, 1254-1255. Blank et al confirm that one-lung ventilation (OLV) is not without risk, but I have grave doubts about whether it is reasonable to conclude that “advances in our understanding of protective ventilation during OLV are likely to derive from well-designed randomized trials controlling for variables of inherent pathophysiologic […]
Read MoreAuthor: Hans-Joachim Priebe, M.D. Anesthesiology 12 2016, Vol.125, 1246-1247. I read with great interest the publication by Ramsingh et al. which elegantly shows that point-of-care ultrasound examination is considerably more accurate than chest auscultation in discriminating between endotracheal and endobronchial intubation. However, several factors limit the practicality of this technique in routine clinical practice. It requires unrestricted access […]
Read MoreAuthors: Mohammad El-Orbany, M.D. Anesthesiology 12 2016, Vol.125, 1248 I read with interest the article by Ramsingh et al regarding point-of-care ultrasound verification of endotracheal tube (ETT) insertion depth. Numerous tests had been previously utilized to prevent and/or detect inadvertent endobronchial (main stem) intubation. Each one of these tests has its own advantages and limitations. Undoubtedly, the use […]
Read MoreAuthors: Antoinette Van Meter, M.D. et al Anesthesiology 12 2016, Vol.125, 1220. IMPLANTED vascular access devices enable patients to receive long-term therapy, including chemotherapy, parenteral nutrition, and blood transfusions. While portal cathethers (PACs) rarely fracture (incidence, 0.4 to 1.8%), the most common location of fractures is at the space between the clavicle and the first […]
Read MoreAuthors: Wei Zhang, M.D. et al Anesthesiology 12 2016, Vol.125, 1251-1252. In a prospective, randomized, and placebo-controlled trial, Lee et al.1 recently showed that administration of 20% exogenous albumin immediately before surgery increases urine output during surgery and reduces the risk of acute kidney injury (AKI) after off-pump coronary artery bypass surgery in patients with a preoperative serum […]
Read MoreAuthors: Gianmaria Cammarota, M.D., Ph.D. et al Anesthesiology 12 2016, Vol.125, 1181-1189 Background: Compared to pneumatically controlled pressure support (PSP), neurally adjusted ventilatory assist (NAVA) was proved to improve patient–ventilator interactions, while not affecting comfort, diaphragm electrical activity (EAdi), and arterial blood gases (ABGs). This study compares neurally controlled pressure support (PSN) with PSP and NAVA, delivered […]
Read MoreAuthors: Wenhua Zhang, M.D. et al Anesthesiology 12 2016, Vol.125, 1130-1135. Background: The median effective dose (ED50) of intranasal dexmedetomidine after failed chloral hydrate sedation has not been described for children. This study aims to determine the ED50 of intranasal dexmedetomidine for rescue sedation in children aged 1 to 36 months, who were inadequately sedated by chloral hydrate […]
Read MoreAuthors: John W. Eikelboom, M.B.B.S. et al Anesthesiology 12 2016, Vol.125, 1121-1129 Background: The PeriOperative ISchemia Evaluation-2 (POISE-2) trial compared aspirin with placebo after noncardiac surgery. Methods: The authors randomly assigned 10,010 patients undergoing noncardiac surgery to receive 200 mg aspirin or placebo 2 to 4 h before surgery and then 100 mg aspirin daily or placebo daily for up to 30 days after […]
Read More